TickerFacts.

Atossa Therapeutics, Inc. (ATOS): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2015-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$132.4K
Year ended 2015-12-31
+54.7%
3-year compound annual growth
$345.5K2011-12-31: $5.2K2012-12-31: $35.7K2013-12-31: $345.5K2014-12-31: $02015-12-31: $132.4K$132.4K
2011-12-31 Cost of Revenue (USD) 2015-12-31
Period endedCost of RevenueChange YoYSource filing
2015-12-31$132.4Kn/a2017-03-21, From 2015-01-01
2014-12-31$0-100.0%2016-03-30, From 2014-01-01
2013-12-31$345.5K+866.6%2015-03-30, From 2013-01-01
2012-12-31$35.7K+592.2%2014-03-27, From 2012-01-01
2011-12-31$5.2Kn/a2013-03-28, From 2011-01-01